Similar articles for PMID: 26260717

Year	Number of Results
1994	1
1995	1
1998	1
1999	1
2004	1
2006	2
2007	3
2008	2
2009	5
2010	2
2011	4
2012	6
2013	9
2014	8
2015	15
2016	6
2017	4
2018	3
2019	6
2020	6
2021	3
2022	3
2023	3
2024	0

1

Remission From Behavioral Dysregulation in a Child With PTSD After Receiving Procedural Ketamine.

Donoghue AC, Roback MG, Cullen KR. Donoghue AC, et al. Pediatrics. 2015 Sep;136(3):e694-6. doi: 10.1542/peds.2014-4152. Epub 2015 Aug 10. Pediatrics. 2015. PMID: 26260717 Free PMC article. Review.

2

Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression.

Albott CS, Lim KO, Forbes MK, Erbes C, Tye SJ, Grabowski JG, Thuras P, Batres-Y-Carr TM, Wels J, Shiroma PR. Albott CS, et al. J Clin Psychiatry. 2018 May/Jun;79(3):17m11634. doi: 10.4088/JCP.17m11634. J Clin Psychiatry. 2018. PMID: 29727073 Clinical Trial.

3

Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.

Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwood K, Aan Het Rot M, Lapidus KA, Wan LB, Iosifescu D, Charney DS. Feder A, et al. JAMA Psychiatry. 2014 Jun;71(6):681-8. doi: 10.1001/jamapsychiatry.2014.62. JAMA Psychiatry. 2014. PMID: 24740528 Clinical Trial.

4

Repeated ketamine infusions for antidepressant-resistant PTSD: Methods of a multicenter, randomized, placebo-controlled clinical trial.

Abdallah CG, Roache JD, Averill LA, Young-McCaughan S, Martini B, Gueorguieva R, Amoroso T, Southwick SM, Guthmiller K, López-Roca AL, Lautenschlager K, Mintz J, Litz BT, Williamson DE, Keane TM, Peterson AL, Krystal JH; Consortium to Alleviate PTSD. Abdallah CG, et al. Contemp Clin Trials. 2019 Jun;81:11-18. doi: 10.1016/j.cct.2019.04.009. Epub 2019 Apr 15. Contemp Clin Trials. 2019. PMID: 30999057

5

The emergence of ketamine as a novel treatment for posttraumatic stress disorder.

Feder A, Rutter SB, Schiller D, Charney DS. Feder A, et al. Adv Pharmacol. 2020;89:261-286. doi: 10.1016/bs.apha.2020.05.004. Epub 2020 Jun 19. Adv Pharmacol. 2020. PMID: 32616209 Review.

6

Ketamine for posttraumatic stress disorder.

Rasmussen KG. Rasmussen KG. JAMA Psychiatry. 2015 Jan;72(1):94-5. doi: 10.1001/jamapsychiatry.2014.1621. JAMA Psychiatry. 2015. PMID: 25564790 No abstract available.

7

Ketamine for posttraumatic stress disorder--reply.

Feder A, Murrough JW. Feder A, et al. JAMA Psychiatry. 2015 Jan;72(1):95-6. doi: 10.1001/jamapsychiatry.2014.1751. JAMA Psychiatry. 2015. PMID: 25564791 No abstract available.

8

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. Zarate CA Jr, et al. Arch Gen Psychiatry. 2006 Aug;63(8):856-64. doi: 10.1001/archpsyc.63.8.856. Arch Gen Psychiatry. 2006. PMID: 16894061 Clinical Trial.

9

Effects of ketamine on major depressive disorder in a patient with posttraumatic stress disorder.

Womble AL. Womble AL. AANA J. 2013 Apr;81(2):118-9. AANA J. 2013. PMID: 23971230

10

Ketamine-induced affective switch in a patient with treatment-resistant depression.

Banwari G, Desai P, Patidar P. Banwari G, et al. Indian J Pharmacol. 2015 Jul-Aug;47(4):454-5. doi: 10.4103/0253-7613.161277. Indian J Pharmacol. 2015. PMID: 26288483 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

82 results

Results by year